Download PDFPDF
EP887 A synergistic anticancer effect of combination treatment with a cell cycle checkpoint kinase 1 inhibitor and PARP inhibitor in BRCA wild type epithelial ovarian cancer
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address